![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Sodium flurbiprofen 0.3%, Ocufen (Allergan), is the first commercially available NSAID for topical ophthalmic use. At this time, its sole approved indication is for the prevention of miosis at the time of cataract surgery. This drug or similar agents may have clinical usefulness as adjuncts in controlling intraocular inflammation, but further studies demonstrating their long-term efficacy and toxicity are required.